Literature DB >> 11410314

Using HIV-1 sequence variability to explore virus biology.

K M McGrath1, N G Hoffman, W Resch, J A Nelson, R Swanstrom.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) only recently established an epidemic world-wide infection in the human population. The virus persists in the human host through active replication and is able to avoid clearance by the immune system. Active replication is an important component of the rapid evolutionary potential of HIV-1, a potential which manifests itself in the evolution of immune escape variants, drug resistant variants, and variants with the ability to use different cell surface coreceptors in conjunction with CD4. Multiple zoonotic introductions, compartmentalization of virus replication in the body, and genetic bottlenecks associated with sampling during transmission, antiretroviral therapy, and geographic and/or host population isolation further contribute to the range of sequences present in extant viruses. The sum of the history of all of these phenomena is reflected in HIV-1 sequence variability, and most of these phenomena are ongoing today. Here we review the use of HIV-1 sequence variability to explore its underlying biology.

Entities:  

Mesh:

Year:  2001        PMID: 11410314     DOI: 10.1016/s0168-1702(01)00271-4

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  14 in total

1.  HIV variability in the liver and evidence of possible compartmentalization.

Authors:  Jason T Blackard; Gang Ma; Christina M Martin; Susan D Rouster; M Tarek Shata; Kenneth E Sherman
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-04       Impact factor: 2.205

2.  A three-dimensional model of the human immunodeficiency virus type 1 integration complex.

Authors:  Jerome Wielens; Ian T Crosby; David K Chalmers
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

3.  Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells.

Authors:  Patrick R Harrington; David W Haas; Kimberly Ritola; Ronald Swanstrom
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Distinct human immunodeficiency virus type 1 subtype A virus circulating in West Africa: sub-subtype A3.

Authors:  Seema Thakore Meloni; Bohye Kim; Jean-Louis Sankalé; Donald J Hamel; Sodsai Tovanabutra; Souleymane Mboup; Francine E McCutchan; Phyllis J Kanki
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

5.  A naturally occurring substitution in human immunodeficiency virus Tat increases expression of the viral genome.

Authors:  Syed M Reza; Lin-Ming Shen; Rupa Mukhopadhyay; Mihaela Rosetti; Tsafi Pe'ery; Michael B Mathews
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Envelope variants from women recently infected with clade A human immunodeficiency virus type 1 confer distinct phenotypes that are discerned by competition and neutralization experiments.

Authors:  Sally L Painter; Roman Biek; David C Holley; Mary Poss
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  Genetic characterization of hepatitis B virus in peripheral blood leukocytes: evidence for selection and compartmentalization of viral variants with the immune escape G145R mutation.

Authors:  Sibnarayan Datta; Rajesh Panigrahi; Avik Biswas; Partha K Chandra; Arup Banerjee; Pradip K Mahapatra; Chinmoy K Panda; Shekhar Chakrabarti; Sujit K Bhattacharya; Kuntal Biswas; Runu Chakravarty
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

Review 8.  Molecular epidemiology of feline immunodeficiency virus in the domestic cat (Felis catus).

Authors:  Jessica J Hayward; Allen G Rodrigo
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

9.  Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection.

Authors:  Kathryn M Kitrinos; Noah G Hoffman; Julie A E Nelson; Ronald Swanstrom
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 10.  The remarkable frequency of human immunodeficiency virus type 1 genetic recombination.

Authors:  Adewunmi Onafuwa-Nuga; Alice Telesnitsky
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.